[DOI] [PubMed] [Google Scholar] 56.Meier JJ, et al
Additionally, selenium supplementation increased the risk of one type of skin cancer (squamous cell carcinoma) by 25%
With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways
6 Challenges for clinical use of IGF-1R-silencing agents 6.1 Toxicity of IGF-1R antagonists Clinical trials of a large number IGF-1/2, IGF-1R, IRS-1, PI3K and mTOR antagonists have been abandoned due to limited anti-cancer activity, or to the toxicity of these agents (41, 53), further supporting the need to continue studies on LL6 and other molecules that are well tolerated in mice and effective at doses that are not toxic to normal cells (54)
Altered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor
They can track their progress not just by the numbers on the scale but also by improvements in overall well-being and body composition
